Heparin-Bridging Therapy and Risk of Bleeding After Endoscopic Submucosal Dissection for Gastric Neoplasms: a Meta-Analysis.

Veeravich JaruvongvanichTomoki SempokuyaKarn WijarnpreechaPatompong Ungprasert

Published in: Journal of gastrointestinal cancer (2018)

A significantly increased risk of post-ESD bleeding among patients who received heparin-bridging therapy in lieu of anticoagulant compared to patients who did not receive it was demonstrated in this study.

Keyphrases

endoscopic submucosal dissection
venous thromboembolism
atrial fibrillation
growth factor
stem cells
cell therapy
bone marrow